jRCT2071250147招募中不适用
ONO-2416-01: A phase I placebo-controlled, double-blind, randomized, parallel-group study and a phase I uncontrolled, open-label study to evaluate the safety, tolerability, and pharmacokinetics of single and multiple oral doses of ONO-2416 in Japanese healthy adult male subjects
未提供0 个研究点目标入组 86 人开始时间: 待定
适应症
试验速览
- 阶段
- 不适用
- 状态
- 招募中
- 入组人数
- 86
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
- 分配方式
- Randomized
入排标准
- 年龄范围
- 18age old over 至 45age old under（—）
- 性别
- Male
入选标准
- •Japanese healthy adult male subjects
- •18 to 45 years of age, inclusive, at the time of signing the informed consent form
- •BMI of >= 18.5 kg/m^2 and < 25.0 kg/m^2 at screening
排除标准
- •Subjects who are on a treatment for or with a history of respiratory, cardiovascular, psychiatric, neurologic, gastrointestinal, immunologic, hepatic, renal, hematopoietic or endocrine and/or other disease.
- •Subjects with current or with a history of severe allergy to drugs or foods
- •Subjects with current or with a history of drug or alcohol abuse
研究者
相似试验
撤回
1 期
A phase 1, randomized, double-blind, placebo-controlled study investigating the safety, tolerability, pharmacokinetics, and pharmacodynamics of single and multiple ascending doses of VNA-318 in healthy male subjects2024-512106-26-00Vandria SA96
招募中
1 期
A Phase 1b, 2-part, placebo-controlled study to evaluate the efficacy, safety, and PK of PF-07054894 in participants with mild to severe UC.ULCERATIVE COLITIS2022-501047-32-00Pfizer Inc.35
招募中
1 期
A phase 1, double-blind, placebo-controlled, randomized, single ascending dose and multiple ascending dose study to assess the safety, tolerability, and pharmacokinetics of GHF-201 in healthy adult volunteers2024-519813-74-00CCDRD Cooperative Clinical Drug Research and Development AG, GHF-Golden Heart Flower Ltd.32
招募中
不适用
A Phase 3 Study to Evaluate the Efficacy and Safety of Adjunctive KarXT for the Treatment of Mania, With or Without Mixed Features,in Bipolar-I Disorder TakingLithium, Valproate, or Lamotrigine (CN0120046)Bipolar-I DisorderjRCT204125017027
招募中
1 期
A Phase 1, Randomized, Double-Blind, Placebo-Controlled, Multiple Ascending Dose Study to Assess the Safety, Tolerability, and Pharmacokinetics of ATX3042024-514744-91-00Betagenon AB, Betagenon AB40